ASTH · Astrana Health Inc
United States · RS rating 75 · As of 2026-11-03
| Price | 36.73 USD |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 75 / 56 / 72 / 66 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 38 / 28 / 53 |
| Industry group (rank) | Medical-Managed Care (13) |
| EPS growth Q/Q | +141.7% |
| Sales growth Q/Q | -0.6% |
| Distance from 52-week high | +26.3% |
| Market cap (USD) | $1.8B |